Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.
For context, the skin has three layers; the visible epidermis ... But the hypodermis, which is made from connective tissue and fat, is vital to providing structure and support to the body ...